RHABDOID TUMOR OF THE KIDNEY (RTK)

Clinical trials for RHABDOID TUMOR OF THE KIDNEY (RTK) explained in plain language.

Never miss a new study

Get alerted when new RHABDOID TUMOR OF THE KIDNEY (RTK) trials appear

Sign up with your email to follow new studies for RHABDOID TUMOR OF THE KIDNEY (RTK), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Trials to join now! 1

New hope for kids with devastating rare cancers

Disease control Recruiting now

This study is testing a combination of three drugs—tazemetostat, nivolumab, and ipilimumab—as a potential treatment for children and young adults with rare, aggressive cancers caused by missing specific proteins (INI1 or SMARCA4). The first part aims to find the safest dose, and …

Matched conditions: RHABDOID TUMOR OF THE KIDNEY (RTK)

Phase: PHASE1, PHASE2 • Sponsor: Susan Chi, MD • Aim: Disease control

Last updated Apr 03, 2026 14:42 UTC

RHABDOID TUMOR OF THE KIDNEY (RTK)

Get alerted when new RHABDOID TUMOR OF THE KIDNEY (RTK) trials appear

New hope for kids with devastating rare cancers